• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB 25GA STELLARIS PC VITRECTOMY PROBE; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB 25GA STELLARIS PC VITRECTOMY PROBE; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number BL5625S
Device Problem Suction Failure (4039)
Patient Problems Intraocular Pressure Increased (1937); Retinal Detachment (2047); Capsular Bag Tear (2639)
Event Date 05/22/2023
Event Type  Injury  
Manufacturer Narrative
The product is not available for return so unable to investigate further for the root cause.Manufacturing and sterilization records were reviewed and found to be acceptable.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.No corrective action required.
 
Event Description
The user facility in france reported that during cataract surgery, an anterior vitrectomy was performed, and the vitrectomy probe failed to aspirate the vitreous.The surgeon reported there were no abnormality before starting the surgery nor at the beginning of the intervention.The surgeon pushed the vitreous with an ophthalmic visco-surgical device allowing the vitreous to be pushed back as far as possible towards the back of the eye.The position of vitreous in the anterior chamber induced an immediate consequence of pupil deformation, poor visual acuity recovery, significant retinal detachment because the vitreous which is still attached to the retina, pulls on it as it passes through the back of the eye to the anterior chamber following iatrogenic posterior capsular rupture.Moreover, the stagnation of the vitreous in the irido-corneal angle in post-op induced an increased intraocular pressure.The surgery lasted approximately one (1) hour, without additional anesthesia.There was an increase in the dose of local corticosteroids post-op as well as subconjunctival injection of celestene the first two days after surgery.On day two post-op, the surgeon sent the patient to the ophthalmological emergency room for revision surgery with anterior vitrectomy because the presence of vitreous in the anterior chamber was too high.
 
Event Description
Iop post-surgery at d1 was 28mmhg, it was treated with diamox (acetazolamid) 250mg x 3 per day via oral route and 1 capsule of diffu k (potassium chloride) in the evening.The patient was sent by surgeon to another hcf for revision surgery.
 
Manufacturer Narrative
Additional information added to b5.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
25GA STELLARIS PC VITRECTOMY PROBE
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
BAUSCH + LOMB
rochester NY 14609
Manufacturer (Section G)
BAUSCH + LOMB, INC.
3365 tree ct. industrial blvd.
st. louis MO 63122
Manufacturer Contact
juli moore
3365 tree ct. industrial blvd.
st. louis, MO 63122
6362263220
MDR Report Key17334194
MDR Text Key319185385
Report Number0001920664-2023-70070
Device Sequence Number1
Product Code HQC
UDI-Device Identifier00757770059843
UDI-Public(01)00757770059843(17)231024(10)X1863
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K101325
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/24/2023
Device Model NumberBL5625S
Device Lot NumberX1863
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/17/2023
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-